Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Clifford R. Jack, David S. Knopman, William J. Jagust et al. · The Lancet Neurology · 2009 · 4.6K citations · Full text

Alzheimer's Disease, Dementia, Biomarkers +10

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Leslie M. Shaw, Hugo Vanderstichele, Małgorzata Knapik-Czajka et al. · Annals of Neurology · 2009 · 2.1K citations · Full text

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

Clifford R. Jack, Val J. Lowe, Stephen D. Weigand et al. · Brain · 2009 · 1.1K citations · Full text

Pib Change, Pathological Events, Neuroimaging Biomarkers +15

Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults

Anne M. Fagan, Catherine M. Roe, Chengjie Xiong et al. · Archives of Neurology · 2007 · 897 citations

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease

Pankaj Mehta, Tuula Pirttilä, Sangita P. Mehta et al. · Archives of Neurology · 2000 · 582 citations